基于牛的混合药物作为潜在的抗癌治疗剂:体外,体外评估

Saltanat Nakypova1, Andrey Smolobochkin2, Tanzilya Rizbayeva2

  • 1Faculty of Chemistry and Chemical Technology, Al Farabi Kazakh National University, Al-Farabi Avenue 71, Almaty 050040, Kazakhstan.

概括

基于牛的混合结构显示出作为新的抗瘤剂的前景. 化合物4p对癌细胞产生显著的抗增殖作用,并改善了小鼠的存活率,这表明药物发现的潜在支架.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K